Health & Safety Industry Today

Mass Spectrometry Market Poised for 7.7% CAGR Growth Through 2031 Amid Tech Innovations

This press release highlights the mass spectrometry market's pivotal role in scientific advancement, projecting a 7.7% CAGR from 2025 to 2031 amid innovations in hybrid technology and applications like proteomics and environmental analysis. It details key segments, end-users, leading companies such as Bruker and PerkinElmer, and regional dynamics with North America leading and Asia-Pacific accelerating. Recent trends emphasize portable systems and AI integration, positioning the market for sustained growth through 2031 without specific numerical data beyond the stated CAGR.
Published 13 January 2026

United States of America – January 13, 2025 – The mass spectrometry market stands at the forefront of analytical innovation, equipping scientists with powerful tools for molecular identification across diverse fields. Leading firms propel this growth through cutting-edge developments tailored to pharmaceutical, biotech, and environmental needs. The Mass Spectrometry Market is expected to register a CAGR of 7.7% from 2025 to 2031, signaling robust expansion ahead.

Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPRE00007737/

Market Overview

Mass spectrometry technology underpins breakthroughs in proteomics, metabolomics, and pharmaceutical analysis by delivering unmatched precision in sample characterization. Hybrid systems dominate for their ability to handle complex matrices, while simple variants support everyday lab workflows. Applications span environmental monitoring, forensic investigations, clinical diagnostics, and food safety testing.

Core segments define the ecosystem:

  • By Technology: Simple, hybrid, others – hybrid excels in resolution for demanding research.
  • By Application: Proteomics, metabolomics, environmental analysis, pharmaceutical analysis, forensic applications, clinical applications, others.
  • End Users: Pharmaceutical and biotechnology companies, research labs and academic institutes, environment testing labs, food and beverage industry, forensic labs, others.

Key players like AB Sciex Pte. Ltd., Bio-Rad Laboratories, Bruker, JEOL Ltd., Kore Technology Limited, LECO Corporation, MKS Instruments, PerkinElmer Inc., and Rigaku Corporation lead with specialized instruments and software advancements.

Recent Developments

Industry momentum builds as companies roll out next-generation mass spectrometry solutions. Portable units gain traction for on-site analysis in remote settings, enhancing efficiency in environmental and forensic work. Integration of AI streamlines data interpretation, accelerating discoveries in drug development and biomarker research.​

Recent initiatives highlight global commitment. Labs worldwide adopt hybrid mass spectrometry for superior sensitivity in clinical applications, while pharma firms leverage it for quality control. These efforts align with the projected trajectory where the Mass Spectrometry Market is expected to register a CAGR of 7.7% from 2025 to 2031.​

Updated Market News

Recent headlines underscore momentum in the mass spectrometry market. In late 2025, Agilent Technologies opened a Biopharma Experience Centre in Hyderabad, India, focusing on chromatography and mass spectrometry for real-world R&D workflows. Thermo Fisher Scientific expanded its triple quadrupole offerings in May 2024, boosting quantitation for pharmaceutical research, while SCIEX launched the ZenoTOF 8600 system in June 2025, delivering up to tenfold sensitivity gains through advanced ion sources.​

PerkinElmer Inc. acquired a niche analytical firm in August 2024 to bolster environmental testing capabilities, and Rigaku introduced a benchtop model for labs in March 2024. These moves reflect industry commitment to AI integration and miniaturization, addressing needs in clinical diagnostics and forensics. In India, NEIGRIHMS unveiled a GC-MS facility in Shillong in August 2025, enhancing regional forensic toxicology.

Market Size, Share, Trends, Analysis, and Forecast by 2031

The mass spectrometry market aligns with sustained growth patterns, driven by R&D demands and tech refinements. The Mass Spectrometry Market is expected to register a CAGR of 7.7% from 2025 to 2031 across global and regional fronts.

  • Global Market Size: Scales steadily through 2031, reflecting demand in pharma and biotech sectors.
  • Market Share: Hybrid technology captures prominent position; pharmaceutical end-users lead adoption.
  • Key Trends: Shift toward portable and AI-enhanced systems, ambient ionization methods, miniaturization for field use.
  • Global Analysis: North America holds strong footing via advanced infrastructure; Asia-Pacific accelerates with manufacturing hubs.
  • Regional Analysis: Europe emphasizes regulatory compliance in environmental testing; Latin America and Middle East expand via investments.
  • Forecast to 2031: Consistent CAGR of 7.7% from 2025 supports expansion in proteomics and clinical apps, with hybrid tech prevailing.

Global and Regional Dynamics

North America drives mass spectrometry adoption through top-tier research facilities and biotech clusters. Asia-Pacific surges as manufacturing and healthcare investments rise in India, China, and Japan. Europe prioritizes sustainable applications in food and environmental sectors.​

Pharma and biotech companies favor mass spectrometry for drug discovery pipelines, while academic institutes advance fundamental research. Environmental labs rely on it for pollutant tracking, and forensic teams value its evidentiary precision. The Mass Spectrometry Market is expected to register a CAGR of 7.7% from 2025 to 2031, bolstering these regional strengths.

Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPRE00007737/

If you have any special requirements about this Mass Spectrometry Market report, please let us know and we can provide custom report.

Strategic Implications

Mass spectrometry reshapes workflows by enabling faster, more reliable insights without extensive sample prep. Innovations in ionization and detection broaden accessibility for emerging markets. As the Mass Spectrometry Market is expected to register a CAGR of 7.7% from 2025 to 2031, stakeholders’ position for collaborative gains.

This trajectory underscores mass spectrometry's role in tackling global challenges like disease diagnostics and ecosystem protection. Industry leaders invest in user-friendly interfaces, ensuring broader integration across end-user segments.​

Related Reports

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch

Other Industry News

Ready to start publishing

Sign Up today!